You are here

retinal vein occlusion

Regeneron, Bayer Build Retinal Vein Occlusion Case for Eylea as Biosimilar Pressure Mounts

BioSpace

Wed, 12/18/24 - 11:12 am

retinal vein occlusion

FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

BioSpace

Fri, 10/27/23 - 11:34 am

retinal vein occlusion

Amid Eylea showdown, Roche's Vabysmo shows durability in retinal vein occlusion

Fierce Pharma

Wed, 10/11/23 - 10:13 am

retinal vein occlusion

FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

BioSpace

Tue, 05/9/23 - 12:27 pm

retinal vein occlusion

Trials cue up new use for Roche's eye disease drug Vabysmo

Pharmaphorum

Fri, 02/10/23 - 10:24 am

clinical trials

retinal vein occlusion

Allergan’s intravitreal implant wins approval in China

Drug Delivery Business News

Mon, 10/30/17 - 09:54 am

intravitreal implants

retinal vein occlusion

Bayer nabs new Eylea nod to help it toward 2015 sales target

Fierce Pharma

Fri, 02/27/15 - 06:59 pm

retinal vein occlusion

Lucentis improves sight after 7 days in 2 studies

Reuters

Mon, 10/5/09 - 10:49 am

retinal vein occlusion